You are here: Industry Insights > COPD

News List

Propeller Health announces My Pharmacy, enabling in-app pharmacy experience for patients with asthma and COPD firstwordpharm
January 10, 2019
Propeller Health, a leading digital therapeutics company, today announced My Pharmacy, connecting Propeller users living with asthma and chronic obstructive pulmonary disease (COPD) directly to pharmacy services in the Propeller mobile app.
ResMed to acquire connected inhaler developer Propeller Health for $225M fiercebiotech
January 03, 2019
Former Fierce 15 winner Propeller Health is being acquired by ResMed in a $225 million deal that aims to broaden the reach of its connected respiratory devices to patients across all stages of chronic obstructive pulmonary disease (COPD).....
AZ’s new COPD inhaler Bevespi Aerosphere approved in EU pharmaphorum
December 24, 2018
AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive pulmonary disease (COPD).
Verona initiates Phase II trial for COPD powder inhaler pharmatimes
December 18, 2018
Verona has announced the start of a Phase II clinical trial to evaluate the pharmacokinetic profile, efficacy and safety of a dry powder inhaler (DPI) formulation of RPL554, for use in patients with moderate to severe...
Circassia takes on full US rights to AZ’ Tudorza pharmatimes
December 13, 2018
The firm already promotes the COPD therapy in the US under a profit share arrangement covering the drug and fellow COPD therapy Duaklir (aclidinium/formoterol), established by the two companies in April last year.
AI app decreases symptoms of COPD, study finds pharmatimes
December 11, 2018
A new clinical study has found that Kaia Health’s artificial intelligence app successfully decreases symptoms of Chronic Obstructive Pulmonary Disease (COPD).
Biofourmis, Brigham and Women’s Hospital collaborate to co-develop Biovitals biospectrumasia
November 29, 2018
Biofourmis, a fast-growing digital health startup that augments personalized care using digital therapeutics, has entered into a collaboration with Brigham and Women’s Hospital...
One in three COPD patients believe they would get better care with different disease pharmatimes
November 26, 2018
One third of patients with chronic obstructive pulmonary disease (COPD) feel they would receive better care if they had cancer, diabetes or heart disease, according to a new Chiesi-sponsored patient survey.
Study suggests positive airway pressure therapy could reduce COPD patient hospitalizations biospectrumasia
November 16, 2018
Singapore - COPD hospitalizations are at an all-time high. The 30-day readmission rate for patients ranges from 20-39 percent, with related healthcare costs at an estimated $50 billion
Mylan and Theravance’s COPD treatment gets FDA approval expressbpd
November 12, 2018
The treatment, Yupelri, is a once-daily inhalable solution to be used by patients of COPD

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page